Biomoles, Inc., located in scenic Seattle — one of the world's largest biotechnology centers in the United States, is a dynamic biotechnology corporation focusing on research and development of innovative and high-quality biological research reagents and biomedical diagnostic devices.
Biomoles' dedication to excellence starts at the top. Biomoles is committed to providing products and services with high quality and competitive price to scientists worldwide in biomedical research and diagnostic communities.
Biomoles began with development and commercialization of advanced high quality reagents for the preparation and isolation of nucleic acid and protein as well as molecular biological solutions and PCR products. Biomoles newly launched new generation precast gels — RedTrack Precast Agarose Gels and GreenTrack Precast Agarose Gels are able to visualize as low as 10bp DNA fragments in minimal amount with remarkable image resolution and mutagen free surroundings.
It is also working aggressively to develop its new lines of innovative products — Smartarray™ Early Cancer Gene Detection System and Liquid-array Gene Diagnosis Kit. This line of products is designed to replace the traditional ways of lab diagnostic methods and provide more precise, rapid and early detection for cancer and infection caused diseases.